...
首页> 外文期刊>Neurochemical research >Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3 beta and mTOR Signalling Pathways
【24h】

Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3 beta and mTOR Signalling Pathways

机译:Asiatical的神经营养作用,Centella Asiatica的慢性1-甲基4-苯基1,2,3,6-四氢吡啶的盐酸盐/丙二酸小鼠模型:MAPK,PI3K-AKT-GSK3 Beta和MTOR的作用 信令途径

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Regulation of various signalling (Ras-MAPK, PI3K and AKT) pathways by augmented activity of neurotrophic factors (NTFs) could prevent or halt the progress of dopaminergic loss in Parkinson's disease (PD). Various in vitro and in vivo experimental studies indicated anti-parkinsonic potential of asiatic acid (AA), a pentacyclic triterpene obtained from Centella asiatica. So the present study is designed to determine the neurotrophic effect of AA against 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine hydrochloride/probenecid (MPTP/p) neurotoxicity in mice model of PD. AA treatment for 5 weeks significantly attenuated MPTP/p induced motor abnormalities, dopamine depletion and diminished expressions NTFs and tyrosine kinase receptors (TrKB). We further, revealed that AA treatment significantly inhibited the MPTP/p-induced phosphorylation of MAPK/P38 related proteins such as JNK and ERK. Moreover, AA treatment increased the phosphorylation of PI3K, Akt, GSK-3 beta and mTOR, suggesting that AA activated PI3K/Akt/mTOR signalling pathway, which might be the cause of neuroprotection offered by AA. The present findings provided more elaborate in vivo evidences to support the neuroprotective effect of AA on dopaminergic neurons of chronic Parkinson's disease mouse model and the potential of AA to be developed as a possible new therapeutic target to treat PD.
机译:通过增强神经营养因子(NTFS)的各种信号(RAS-MAPK,PI3K和AKT)途径的调节可以预防或停止帕金森病(PD)中多巴胺能失去的进展。各种体外和体内实验研究表明了亚自亚酸(AA)的抗帕金氏菌潜力,从Centella Asiatica获得了戊基三萜。因此,本研究设计用于确定PD小鼠模型中的1-甲基4-苯基1,2,3,6-四氢吡啶盐酸/丙烯酸(MPTP / P)神经毒性的AA的神经营养效果。 AA治疗5周明显减弱MPTP / P诱导的电动机异常,多巴胺耗尽和表达次数减少NTFS和酪氨酸激酶受体(TRKB)。进一步证实,AA治疗显着抑制MAPK / P38相关蛋白如JNK和ERK的MAPK / P38相关蛋白的磷酸化。此外,AA治疗增加了PI3K,AKT,GSK-3β和MTOR的磷酸化,表明AA活化的PI3K / AKT / MTOR信号传导途径,这可能是AA提供的神经保护的原因。本研究结果提供了更详细的体内证据,以支持AA对慢性帕金森病小鼠模型的多巴胺能神经元的神经保护作用以及作为可能的新治疗靶标的AA的可能性来治疗PD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号